The UK’s MHRA has approved the first GLP-1 receptor agonist tablet for weight loss, offering a more convenient alternative to weekly injections. Semaglutide, branded as Wegovy, is now available in pill form for adults with obesity or those who are overweight with weight-related health conditions. Patients can transition directly from the weekly injection to the 25 mg daily tablet.
